RE: price rise13 Aug 2020 11:53
Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 90 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title: A First in Human, Double-blind, Placebo-controlled, Multicentre Phase I/II Study to Evaluate the Safety, Tolerability and Immune Modulatory Effects of MRx-4DP0004 in Participants Taking Long-term Control Medication for Their Asthma
Actual Study Start Date : July 4, 2019
Estimated Primary Completion Date : September 2020
Estimated Study Completion Date : September 2020